Registration is now open for the May 8 webinar, “Misoprostol for Postpartum Hemorrhage: Advocacy, Approval, Access.” The webinar will be hosted by Family Care International, Gynuity Health Projects, PATH and Population Services International.
From the webinar announcement:
Misoprostol is a safe and effective medicine for preventing and treating postpartum hemorrhage, the leading cause of maternal death. While it is practical for use both at health facilities and in home births, it is not widely available or accessible in many countries.
In this free, interactive hour-long webinar, learn from the experts how focused advocacy can drive policy change and ensure women’s access to this essential medicine.
To register, click here.
For more, check out the MHTF blog’s recent guest post on misoprostol for treatment of postpartum hemorrhage by FCI President Ann Starrs and Gynuity Health Projects President Beverly Winikoff.